Maladies inflammatoires de l'intestin [Main therapeutic advances in IBD in 2008]

Details

Ressource 1Download: RMS_idPAS_D_ISBN_pu2009-03s_sa04_art04.pdf (410.50 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_2DA4F8AFD844
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
UNIL/CHUV
Title
Maladies inflammatoires de l'intestin [Main therapeutic advances in IBD in 2008]
Journal
Revue Médicale Suisse
Author(s)
Felley C., Mottet C., Hess J., Maillard M.H., Delarive J., Michetti P.
ISSN
1660-9379
Publication state
Published
Issued date
2009
Peer-reviewed
Oui
Volume
5
Number
187
Pages
185-194
Language
french
Abstract
A coimmunosuppression with azathioprine or methotrexate in addition to infliximab does not improve the therapeutic efficacy in Crohn's disease but increase the risks of infectious complications and neoplasia.
Keywords
Chemoprevention, Gastrointestinal Agents, Humans, Inflammatory Bowel Diseases, Tumor Necrosis Factor-alpha
URN
urn:nbn:ch:serval-BIB_2DA4F8AFD8440
OAI-PMH
oai:serval.unil.ch:BIB_2DA4F8AFD844
DOI
10.53738/REVMED.2009.5.187.0185
Pubmed
19271429
Create date
17/04/2009 18:07
Last modification date
20/10/2024 6:26
Usage data